Skip to main content

Table 1 Patient characteristics

From: Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder

 

All subjects N = 33

Mean age, years ± SD

46 ± 6.5

   Range

29–55

Sex, %

 

   Women

85

   Men

15

Mean age at onset of PTSD, years ± SD

29 ± 15

   Range

2–53

Mean duration of PTSD history, years ± SD

18 ± 15

   Range

0–46

Patients with comorbid disorders, N (%)

 

   Bipolar disorder

10 (30)

   Major depressive disorder

21 (64)

   Substance abuse

 

Current

3 (9)

In past

5 (15)

  1. SD =standard deviation; PTSD = posttraumatic stress disorder.